Cas:289630-80-4 1-(5,7-dimethyl-1,8-naphthyridin-2-yl)-1-(3-methylphenyl)urea manufacturer & supplier

We serve Chemical Name:1-(5,7-dimethyl-1,8-naphthyridin-2-yl)-1-(3-methylphenyl)urea CAS:289630-80-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-(5,7-dimethyl-1,8-naphthyridin-2-yl)-1-(3-methylphenyl)urea

Chemical Name:1-(5,7-dimethyl-1,8-naphthyridin-2-yl)-1-(3-methylphenyl)urea
CAS.NO:289630-80-4
Synonyms:1-(5,7-dimethyl-1,8-naphthyridin-2-yl)-1-(3-methylphenyl)urea
Molecular Formula:C18H18N4O
Molecular Weight:306.36200
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:73.10000
Exact Mass:306.14800
LogP:4.28560

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-(5,7-dimethyl-1,8-naphthyridin-2-yl)-1-(3-methylphenyl)urea chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(5,7-dimethyl-1,8-naphthyridin-2-yl)-1-(3-methylphenyl)urea physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(5,7-dimethyl-1,8-naphthyridin-2-yl)-1-(3-methylphenyl)urea Use and application,1-(5,7-dimethyl-1,8-naphthyridin-2-yl)-1-(3-methylphenyl)urea technical grade,usp/ep/jp grade.


Related News: According to Plexxikon, GSK scientists were only able to make Tafinlar after talks with Plexxikon about a potential partnership; although those talks never turned into a licensing deal, GSK apparently channeled that information and created a rival drug. ethylmercury phosphate manufacturers The Company most recently announced plans to establish a dedicated laboratory space with Biosafety Level-3 (BSL-3) containment to handle testing of SARS-CoV-2 (the viral strain causing COVID-19) and other similar pathogens that cause human disease. octyl isothiocyanate suppliers Orchard’s decision last year to put OTL-101 on the back burner left patients with no way to access a seemingly effective therapy for a condition that can kill children before they reach the age of one. 3-Methoxy-2-cyclopenten-1-one vendor & factory.